Cargando…
Evaluation of Thimerosal Removal on Immunogenicity of Aluminum Salts Adjuvanted Recombinant Hepatitis B Vaccine
Thimerosal, which is approximately 50% mercury by weight is a preservative widely used in vaccines since the 1930’s. It meets the requirements for a preservative as set forth by Pharmacopeia challenge test and has been shown to be effective against a broad spectrum of pathogens. In July 1999, the Pu...
Autores principales: | Mahboubi, Arash, Fazeli, Mohammad Reza, Samadi, Nasrin, Dinarvand, Rasoul, Azadi, Saeed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876573/ https://www.ncbi.nlm.nih.gov/pubmed/25317183 |
Ejemplares similares
-
Development and Validation of a Risk Scoring System Derived from Meta-Analyses of Papillary Thyroid Cancer
por: Suh, Sunghwan, et al.
Publicado: (2020) -
Toxicological Effects of Thimerosal and Aluminum in the Liver, Kidney, and Brain of Zebrafish (Danio rerio)
por: Galiciolli, Maria Eduarda Andrade, et al.
Publicado: (2023) -
Safety and immunogenicity of an inactivated thimerosal‐free influenza vaccine in infants and children
por: Nolan, Terry, et al.
Publicado: (2009) -
Immunogenicity of a bivalent killed thimerosal-free oral cholera vaccine, Euvichol, in an animal model
por: Lee, Eun Young, et al.
Publicado: (2018) -
Thimerosal: current sources of contact in Brazil()
por: Rocha, Vanessa Barreto, et al.
Publicado: (2014)